Maurizio  Vecchione is executive vice president of Global Good and Research at  Intellectual Ventures (IV). In this role, Maurizio oversees Global Good,  IV’s collaboration with Bill Gates to invent and deploy technology  specifically focused on improving life in developing countries, as well  as the research and operations of the Intellectual Ventures Laboratory  (IV Lab) and Institute for Disease Modeling. Under his leadership,  Global Good and IV Lab engage in cutting-edge research and invention for  the benefit of humanity around global health and global development  priorities.

Maurizio  has nearly 30 years of experience in research and the technology  sector, most recently serving as CEO of Arrogene and prior to that as  CEO of telemedicine pioneer CompuMed. He has contributed to building  nine startups and helped launch more than 50 commercial products,  resulting in more than $1 billion in shareholder value. His work spans  the software, internet, wireless and life sciences sectors, primarily in  connection with translational sciences for science derived from  government and academic research and development efforts.
Maurizio is involved in several nonprofit initiatives, including his  role as co-founder and member of the board of ReefQuest, a global  organization focused on fostering marine environmental stewardship in  children through citizen science. An inventor, he is named on multiple  U.S. patents and patent applications related to imaging, image  processing, and nano-bio-polymer and telecommunications technologies.  Maurizio studied physics at the University of California, Berkeley.

Maurizio Vecchione has been on the ISSNAF board of Directors since November 2017.